ICD-10-CM Billable Code

M05.579

Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

Rheumatoid polyneuropathy with rheumatoid arthritis affecting the ankle and foot is a condition where rheumatoid arthritis (RA) leads to nerve damage in the peripheral nervous system, specifically impacting the nerves that serve the ankle and foot. This complication arises in individuals with RA, a chronic inflammatory disorder primarily targeting joints, which can sometimes extend its impact beyond joints to involve nerves and other tissues. Recognizing this condition is crucial for managing symptoms and improving quality of life.

Causes & Symptoms

Clinical Causes: Chronic inflammation from rheumatoid arthritis leading to nerve damage Nerve compression due to joint swelling or deformities in the ankle and foot Immune system attacks on the nerves, causing inflammation and demyelination Vascular changes associated with RA reducing blood supply to nerves Side effects of medications used in RA treatment that may affect nerve health Secondary infections or complications from RA that affect nerve tissues

Key Symptoms: Numbness or a tingling sensation in the affected foot or ankle Weakness in the muscles of the foot and ankle, leading to difficulty with movement Pain, which may be sharp, burning, or stabbing in nature Loss of sensation or decreased responsiveness to touch and temperature Decreased coordination or balance issues when standing or walking Muscle wasting in severe cases affecting the foot muscles Foot deformities resulting from nerve weakness and muscle imbalance

Diagnostic & Treatment

Diagnosis Path: Diagnosing rheumatoid polyneuropathy involves a combination of clinical assessment and diagnostic testing. Healthcare providers may perform physical examinations to evaluate nerve function, muscle strength, and reflexes. Additional tests can include nerve conduction studies, electromyography (EMG), and blood tests to identify markers of inflammation and RA activity. Imaging such as X-rays or MRI may be used to assess joint damage, while nerve biopsies are considered in complex cases.

Treatment Protocols: Management strategies focus on controlling rheumatoid arthritis to reduce inflammation and prevent further nerve damage. Specific approaches include: - Anti-inflammatory medications and disease-modifying antirheumatic drugs (DMARDs) to control RA activity - Pain management through analgesics or nerve pain medications - Physical therapy to strengthen muscles, improve mobility, and reduce deformities - Occupational therapy to adapt daily activities and reduce nerve stress - Use of orthotic devices or bracing to support foot structure and improve gait - Addressing nerve compression with surgical interventions if necessary - Monitoring and treating any secondary complications, such as infections or vascular issues Early detection and comprehensive management are key to alleviating symptoms and preventing progression of nerve damage.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M05.579 a billable ICD-10 code?
Yes, M05.579 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M05.579?
Clinical documentation must specify the nature of Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference